KA Pagel, D Antaki, AJ Lian, M Mort… - PLoS computational …, 2019 - journals.plos.org
Differentiation between phenotypically neutral and disease-causing genetic variation remains an open and relevant problem. Among different types of variation, non-frameshifting …
YJ Lin, AS Menon, Z Hu, SE Brenner - Human Genomics, 2024 - Springer
Background Variant interpretation is essential for identifying patients' disease-causing genetic variants amongst the millions detected in their genomes. Hundreds of Variant Impact …
Z Yue, X Chu, J Xia - Briefings in Bioinformatics, 2021 - academic.oup.com
The discrimination of driver from passenger mutations has been a hot topic in the field of cancer biology. Although recent advances have improved the identification of driver …
R Cao, M Wang, Y Bin, C Zheng - PeerJ, 2021 - peerj.com
An emerging type of therapeutic agent, anticancer peptides (ACPs), has attracted attention because of its lower risk of toxic side effects. However process of identifying ACPs using …
Insertions and deletions (Indels) represent one of the major variation types in the human genome and have been implicated in diseases including cancer. To study the features of …
N Shirvanizadeh, M Vihinen - Frontiers in Bioinformatics, 2023 - frontiersin.org
Genetic variation data is nowadays easy to generate. Variation interpretation means the description of the significance of variations, often in relation to disease. This is substantially …
EM Miller, NE Patterson, GM Gressel… - BMC Medical …, 2020 - Springer
Abstract Background The Cancer Genome Atlas identified four molecular subgroups of endometrial cancer with survival differences based on whole genome, transcriptomic, and …
Z Yue, Y Xiang, G Chen, X Wang, K Li… - … /ACM Transactions on …, 2023 - ieeexplore.ieee.org
Inframe insertion/deletion (indel) variants may alter protein sequence and function, which are closely related to an extensive variety of diseases. Although recent researches have …
D Zhang, Y Bin - Frontiers in genetics, 2021 - frontiersin.org
Identification of driver genes from mass non-functional passenger genes in cancers is still a critical challenge. Here, an effective and no parameter algorithm, named DriverSubNet, is …